CompaniesNeuroPharm

NeuroPharm

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

346

By Phase

PHASE3: 3PHASE1/PHASE2: 1PHASE2: 1

By Status

COMPLETED: 3TERMINATED: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
Hover over trial bars to see details

Recent Trials

NCT03417947Collaborator
Vitamin D Supplementation in Children With Sickle Cell Disease
PHASE3Completed
42 participants
Started: Nov 30, 2018 · Completed: Sep 30, 2019
NCT00787111Lead Sponsor
Extended Management and Measurement of Autism
PHASE3Terminated
128 participants
Started: Nov 30, 2008 · Completed: Apr 30, 2009
NCT00637221Lead Sponsor
Open Label Study Investigating Safety and Efficacy of NPL2009 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance Tasks, Adults With Fragile X Syndrome
PHASE1/PHASE2Completed
12 participants
Started: Mar 31, 2008 · Completed: Apr 30, 2008
NCT00515320Lead Sponsor
Study of Fluoxetine in Autism
PHASE3Completed
158 participants
Started: Aug 31, 2007 · Completed: Jan 31, 2009
NCT00515255Lead Sponsor
Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)
PHASE2Terminated
6 participants
Started: Jul 31, 2007 · Completed: Apr 30, 2008
Funding History (1)
D
Dec 4, 2020
Filing